Adenosine-5'-triphosphate up-regulates proliferation of human cardiac fibroblasts

British Journal of Pharmacology

Volumn 166, Issue 3, 2012, Pages 1140-1150

  Chen, Jing Bo ^a   Liu, Wen Juan ^a   Che, Hui ^a   Liu, Jie ^b   Sun, Hai Ying ^a   Li, Gui Rong ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b SHENZHEN UNIVERSITY   (China)

Author keywords

ATP; cardiac fibroblasts; cell cycling; cell migration; proliferation

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; ADENOSINE TRIPHOSPHATE; ADENOSINE TRIPHOSPHATE GAMMAS; ALPHA,BETA METHYLENEADENOSINE TRIPHOSPHATE; CIBACRON BLUE F3GA; CYCLIN D1; CYCLIN E; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PHOSPHATIDYLINOSITOL 3 KINASE INHIBITOR; PROTEIN KINASE B; PROTEIN KINASE B INHIBITOR; PURINERGIC P2X2 RECEPTOR; PURINERGIC P2X4 RECEPTOR; PURINERGIC P2X7 RECEPTOR; PURINERGIC P2Y RECEPTOR AGONIST; SMALL INTERFERING RNA; SURAMIN; TRICIRIBINE; UNCLASSIFIED DRUG; WORTMANNIN;

ADULT; ARTICLE; CARDIAC FIBROBLAST; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL CYCLE PROGRESSION; CELL CYCLE S PHASE; CELL LEVEL; CELL MIGRATION; CELL PROLIFERATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG MECHANISM; DRUG TARGETING; ENZYME PHOSPHORYLATION; FIBROBLAST; GENE EXPRESSION REGULATION; HEART MUSCLE CELL; HEART VENTRICLE; HUMAN; HUMAN CELL; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; RECEPTOR UPREGULATION;

ADENOSINE TRIPHOSPHATE; BLOTTING, WESTERN; CELL CULTURE TECHNIQUES; CELL CYCLE; CELL MOVEMENT; CELL PROLIFERATION; CELLS, CULTURED; DOSE-RESPONSE RELATIONSHIP, DRUG; FIBROBLASTS; FLOW CYTOMETRY; GENE EXPRESSION; HEART; HUMANS; MYOCARDIUM; RECEPTORS, PURINERGIC P2X; RECEPTORS, PURINERGIC P2Y; RNA INTERFERENCE; RNA, SMALL INTERFERING;

EID: 84860843028     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1111/j.1476-5381.2012.01831.x     Document Type: Article

References (49)

1. Ataullakhanov FI, Vitvitsky VM, (2002). What determines the intracellular ATP concentration. Biosci Rep 22: 501-511.
2. Bogdanov Y, Rubino A, Burnstock G, (1998). Characterisation of subtypes of the P2X and P2Y families of ATP receptors in the foetal human heart. Life Sci 62: 697-703.
3. Braun OO, Lu D, Aroonsakool N, Insel PA, (2010). Uridine triphosphate (UTP) induces profibrotic responses in cardiac fibroblasts by activation of P2Y2 receptors. J Mol Cell Cardiol 49: 362-389.
4. Brilla CG, Maisch B, Weber KT, (1992). Myocardial collagen matrix remodelling in arterial hypertension. Eur Heart J 13 (Suppl. D): 24-32.
5. Buolamwini JK, (2000). Cell cycle molecular targets in novel anticancer drug discovery. Curr Pharm Des 6: 379-392.
6. Burnstock G, (1997). The past, present and future of purine nucleotides as signalling molecules. Neuropharmacology 36: 1127-1139.
7. Burnstock G, Ralevic V, (1994). New insights into the local regulation of blood flow by perivascular nerves and endothelium. Br J Plast Surg 47: 527-543.
8. Camelliti P, Green CR, Kohl P, (2006). Structural and functional coupling of cardiac myocytes and fibroblasts. Adv Cardiol 42: 132-149.
9. Cha SH, Hahn TW, Sekine T, Lee KH, Endou H, (2000). Purinoceptor-mediated calcium mobilization and cellular proliferation in cultured bovine corneal endothelial cells. Jpn J Pharmacol 82: 181-187.
10. Chang SJ, Tzeng CR, Lee YH, Tai CJ, (2008). Extracellular ATP activates the PLC/PKC/ERK signaling pathway through the P2Y2 purinergic receptor leading to the induction of early growth response 1 expression and the inhibition of viability in human endometrial stromal cells. Cell Signal 20: 1248-1255.
11. Chen JB, Tao R, Sun HY, Tse HF, Lau CP, Li GR, (2010). Multiple Ca(2+) signaling pathways regulate intracellular Ca(2+) activity in human cardiac fibroblasts. J Cell Physiol 223: 68-75.
12. Cheng JQ, Lindsley CW, Cheng GZ, Yang H, Nicosia SV, (2005). The Akt/PKB pathway: molecular target for cancer drug discovery. Oncogene 24: 7482-7492.
13. Coppi E, Pugliese AM, Urbani S, Melani A, Cerbai E, Mazzanti B, et al,. (2007). ATP modulates cell proliferation and elicits two different electrophysiological responses in human mesenchymal stem cells. Stem Cells 25: 1840-1849.
14. Cordes N, van BD, (2004). Arrest of human lung fibroblasts in G2 phase after irradiation is regulated by converging phosphatidylinositol-3 kinase and beta1-integrin signaling in vitro. Int J Radiat Oncol Biol Phys 58: 453-462.
15. Deng XL, Lau CP, Lai K, Cheung KF, Lau GK, Li GR, (2007). Cell cycle-dependent expression of potassium channels and cell proliferation in rat mesenchymal stem cells from bone marrow. Cell Prolif 40: 656-670.
16. Du J, Guan T, Zhang H, Xia Y, Liu F, Zhang Y, (2008). Inhibitory crosstalk between ERK and AMPK in the growth and proliferation of cardiac fibroblasts. Biochem Biophys Res Commun 368: 402-407.
17. Dugourd C, Gervais M, Corvol P, Monnot C, (2003). Akt is a major downstream target of PI3-kinase involved in angiotensin II-induced proliferation. Hypertension 41: 882-890.
18. Erlinge D, Burnstock G, (2008). P2 receptors in cardiovascular regulation and disease. Purinergic Signal 4: 1-20.
19. Franke H, Sauer C, Rudolph C, Krugel U, Hengstler JG, Illes P, (2009). P2 receptor-mediated stimulation of the PI3-K/Akt-pathway in vivo. Glia 57: 1031-1045.
20. Gerasimovskaya EV, Tucker DA, Weiser-Evans M, Wenzlau JM, Klemm DJ, Banks M, et al,. (2005). Extracellular ATP-induced proliferation of adventitial fibroblasts requires phosphoinositide 3-kinase, Akt, mammalian target of rapamycin, and p70 S6 kinase signaling pathways. J Biol Chem 280: 1838-1848.
21. He ML, Liu WJ, Sun HY, Wu W, Liu J, Tse HF, et al,. (2011). Effects of ion channels on proliferation in cultured human cardiac fibroblasts. J Mol Cell Cardiol 51: 198-206.
22. Heo JS, Han HJ, (2006). ATP stimulates mouse embryonic stem cell proliferation via protein kinase C, phosphatidylinositol 3-kinase/Akt, and mitogen-activated protein kinase signaling pathways. Stem Cells 24: 2637-2648.
23. Kato J, (1999). Induction of S phase by G1 regulatory factors. Front Biosci 4: D787-D792.
24. Kim SE, Lee WJ, Choi KY, (2007). The PI3 kinase-Akt pathway mediates Wnt3a-induced proliferation. Cell Signal 19: 511-518.
25. Li GR, Sun HY, Chen JB, Zhou Y, Tse HF, Lau CP, (2009). Characterization of multiple ion channels in cultured human cardiac fibroblasts. PLoS ONE 4: e7307.
26. Liu JL, Mao Z, LaFortune TA, Alonso MM, Gallick GE, Fueyo J, et al,. (2007). Cell cycle-dependent nuclear export of phosphatase and tensin homologue tumor suppressor is regulated by the phosphoinositide-3-kinase signaling cascade. Cancer Res 67: 11054-11063.
27. Long CS, Brown RD, (2002). The cardiac fibroblast, another therapeutic target for mending the broken heart? J Mol Cell Cardiol 34: 1273-1278.
28. Porter KE, Turner NA, (2009). Cardiac fibroblasts: at the heart of myocardial remodeling. Pharmacol Ther 123: 255-278.
29. Ralevic V, Burnstock G, (1991). Roles of P2-purinoceptors in the cardiovascular system. Circulation 84: 1-14.
30. Santiago-Perez LI, Flores RV, Santos-Berrios C, Chorna NE, Krugh B, Garrad RC, et al,. (2001). P2Y(2) nucleotide receptor signaling in human monocytic cells: activation, desensitization and coupling to mitogen-activated protein kinases. J Cell Physiol 187: 196-208.
31. Schwiebert EM, (2000). Extracellular ATP-mediated propagation of Ca(2+) waves. Focus on 'mechanical strain-induced Ca(2+) waves are propagated via ATP release and purinergic receptor activation'. Am J Physiol Cell Physiol 279: C281-C283.
32. Sherr CJ, Roberts JM, (1999). CDK inhibitors: positive and negative regulators of G1-phase progression. Genes Dev 13: 1501-1512.
33. Souders CA, Bowers SL, Baudino TA, (2009). Cardiac fibroblast: the renaissance cell. Circ Res 105: 1164-1176.
34. Stabile E, Zhou YF, Saji M, Castagna M, Shou M, Kinnaird TD, et al,. (2003). Akt controls vascular smooth muscle cell proliferation in vitro and in vivo by delaying G1/S exit. Circ Res 93: 1059-1065.
35. Su XL, Wang Y, Zhang W, Zhao LM, Li GR, Deng XL, (2011). Insulin-mediated upregulation of K(Ca)3.1 channels promotes cell migration and proliferation in rat vascular smooth muscle. J Mol Cell Cardiol 51: 51-57.
36. Sun Y, Weber KT, (2000). Infarct scar: a dynamic tissue. Cardiovasc Res 46: 250-256.
37. Sun Y, Kiani MF, Postlethwaite AE, Weber KT, (2002). Infarct scar as living tissue. Basic Res Cardiol 97: 343-347.
38. 2+-activated potassium and volume-sensitive chloride channels in mouse mesenchymal stem cells. Am J Physiol Cell Physiol 295: C1409-C1416.
39. Tao R, Sun HY, Lau CP, Tse HF, Lee HC, Li GR, (2011). Cyclic ADP ribose is a novel regulator of intracellular Ca(2+) oscillations in human bone marrow mesenchymal stem cells. J Cell Mol Med 15: 2684-2696.
40. Vassort G, (2001). Adenosine 5'-triphosphate: a P2-purinergic agonist in the myocardium. Physiol Rev 81: 767-806.
41. Vermeulen K, Van Bockstaele DR, Berneman ZN, (2003). The cell cycle: a review of regulation, deregulation and therapeutic targets in cancer. Cell Prolif 36: 131-149.
42. Wang DJ, Huang NN, Heppel LA, (1992). Extracellular ATP and ADP stimulate proliferation of porcine aortic smooth muscle cells. J Cell Physiol 153: 221-233.
43. Wang MX, Ren LM, Shan BE, (2005). Inhibitory effects of extracellular adenosine triphosphate on growth of esophageal carcinoma cells. World J Gastroenterol 11: 5915-5919.
44. Wihlborg AK, Balogh J, Wang L, Borna C, Dou Y, Joshi BV, et al,. (2006). Positive inotropic effects by uridine triphosphate (UTP) and uridine diphosphate (UDP) via P2Y2 and P2Y6 receptors on cardiomyocytes and release of UTP in man during myocardial infarction. Circ Res 98: 970-976.
45. Wilden PA, Agazie YM, Kaufman R, Halenda SP, (1998). ATP-stimulated smooth muscle cell proliferation requires independent ERK and PI3K signaling pathways. Am J Physiol 275: H1209-H1215.
46. Yang JJ, Krauss RS, (1997). Extracellular ATP induces anchorage-independent expression of cyclin A and rescues the transformed phenotype of a ras-resistant mutant cell line. J Biol Chem 272: 3103-3108.
47. Yang K, Guo Y, Stacey WC, Harwalkar J, Fretthold J, Hitomi M, et al,. (2006). Glycogen synthase kinase 3 has a limited role in cell cycle regulation of cyclin D1 levels. BMC Cell Biol 7: 33. doi:10.1186/1471-2121-7-33.
48. Zannad F, Dousset B, Alla F, (2001). Treatment of congestive heart failure: interfering the aldosterone-cardiac extracellular matrix relationship. Hypertension 38: 1227-1232.
49. Zheng JS, O'Neill L, Long X, Webb TE, Barnard EA, Lakatta EG, et al,. (1998). Stimulation of P2Y receptors activates c-fos gene expression and inhibits DNA synthesis in cultured cardiac fibroblasts. Cardiovasc Res 37: 718-728.